2016 Q2 Form 10-Q Financial Statement

#000091142116000093 Filed on May 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q4
Revenue $1.417B $1.379B
YoY Change -2.92% -17.08%
Cost Of Revenue $714.3M $767.0M
YoY Change -0.97% -11.84%
Gross Profit $145.0M $612.0M
YoY Change -39.08% -22.82%
Gross Profit Margin 10.23% 44.38%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $283.0M $311.0M
YoY Change 2.6% -4.31%
% of Gross Profit 195.15% 50.82%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $12.26M $12.00M
YoY Change 0.11% 0.0%
% of Operating Profit
Other Income/Expense, Net $152.7M $120.0M
YoY Change 22.38% -2.44%
Pretax Income $250.0M $169.0M
YoY Change -24.59% -49.4%
Income Tax $30.95M -$3.000M
% Of Pretax Income 12.38% -1.78%
Net Earnings $215.6M $177.0M
YoY Change -12.32% -36.1%
Net Earnings / Revenue 15.22% 12.84%
Basic Earnings Per Share $3.39
Diluted Earnings Per Share $3.30
COMMON SHARES
Basic Shares Outstanding 1.000 shares 47.95M shares 47.91M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.750B $1.577B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $456.4M $456.4M
YoY Change 0.0% 0.0%
Intangibles $126.4M $133.0M
YoY Change -17.28% -16.66%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $21.96B $21.41B
YoY Change -2.37% -3.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $15.05B $14.50B
YoY Change -1.24% -4.37%
SHAREHOLDERS EQUITY
Retained Earnings $4.402B $6.147B
YoY Change -31.67% -1.98%
Common Stock $0.00 $87.24M
YoY Change -100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $3.267B
YoY Change -100.0% 0.24%
Treasury Stock Shares 0.000 shares 39.30M shares
Shareholders Equity $6.910B $6.901B
YoY Change
Total Liabilities & Shareholders Equity $21.96B $21.41B
YoY Change -2.37% -3.88%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income $215.6M $177.0M
YoY Change -12.32% -36.1%
Depreciation, Depletion And Amortization $283.0M $311.0M
YoY Change 2.6% -4.31%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $49.04M
YoY Change 8457.77%
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $200.6M
YoY Change 323.51%
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000911421
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1 shares
CY2016Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
PARTNERRE LTD.
CY2016Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015Q1 pre Increase Decrease In Unpaid Losses And Loss Expenses Including Life Policy Benefits
IncreaseDecreaseInUnpaidLossesAndLossExpensesIncludingLifePolicyBenefits
80728000 USD
CY2016Q1 pre Increase Decrease In Unpaid Losses And Loss Expenses Including Life Policy Benefits
IncreaseDecreaseInUnpaidLossesAndLossExpensesIncludingLifePolicyBenefits
187614000 USD
CY2015Q1 pre Losses And Loss Expenses And Life Policy Benefits Segment Disclosure
LossesAndLossExpensesAndLifePolicyBenefitsSegmentDisclosure
721000000 USD
CY2016Q1 pre Losses And Loss Expenses And Life Policy Benefits Segment Disclosure
LossesAndLossExpensesAndLifePolicyBenefitsSegmentDisclosure
714000000 USD
CY2015Q4 pre Net Tax Assets
NetTaxAssets
102596000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1413799000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1577097000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1749851000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
100331000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
172754000 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2016Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2015Q4 pre Derivative Asset Financial Instruments Not Offset
DerivativeAssetFinancialInstrumentsNotOffset
1037000 USD
CY2016Q1 pre Derivative Asset Financial Instruments Not Offset
DerivativeAssetFinancialInstrumentsNotOffset
2405000 USD
CY2015Q4 pre Derivative Liability Financial Instruments Not Offset
DerivativeLiabilityFinancialInstrumentsNotOffset
1037000 USD
CY2016Q1 pre Derivative Liability Financial Instruments Not Offset
DerivativeLiabilityFinancialInstrumentsNotOffset
2405000 USD
CY2015Q4 pre Funds Held Directly Managed
FundsHeldDirectlyManaged
539743000 USD
CY2016Q1 pre Funds Held Directly Managed
FundsHeldDirectlyManaged
579571000 USD
CY2015Q4 pre Funds Held Directly Managed Cost
FundsHeldDirectlyManagedCost
537661000 USD
CY2016Q1 pre Funds Held Directly Managed Cost
FundsHeldDirectlyManagedCost
572550000 USD
CY2015Q4 pre Funds Held Directly Managed Investments Carried At Fair Value
FundsHeldDirectlyManagedInvestmentsCarriedAtFairValue
399899000 USD
CY2016Q1 pre Funds Held Directly Managed Investments Carried At Fair Value
FundsHeldDirectlyManagedInvestmentsCarriedAtFairValue
426537000 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6768000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6588000 USD
CY2015Q4 us-gaap Assets
Assets
21406043000 USD
CY2016Q1 us-gaap Assets
Assets
21955463000 USD
CY2015Q1 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
1748933000 USD
CY2016Q1 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
1629009000 USD
CY2015Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
1127688000 USD
CY2016Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
1166689000 USD
CY2015Q1 pre Increase Decrease From Issuance Or Sale Of Equity Net Of Taxes Withheld In A Net Share Settlement
IncreaseDecreaseFromIssuanceOrSaleOfEquityNetOfTaxesWithheldInANetShareSettlement
-4084000 USD
CY2016Q1 pre Increase Decrease From Issuance Or Sale Of Equity Net Of Taxes Withheld In A Net Share Settlement
IncreaseDecreaseFromIssuanceOrSaleOfEquityNetOfTaxesWithheldInANetShareSettlement
12938000 USD
CY2015Q1 pre Increase Decrease In Funds Held By Reinsured Companies And Funds Held Directly Managed
IncreaseDecreaseInFundsHeldByReinsuredCompaniesAndFundsHeldDirectlyManaged
71350000 USD
CY2016Q1 pre Increase Decrease In Funds Held By Reinsured Companies And Funds Held Directly Managed
IncreaseDecreaseInFundsHeldByReinsuredCompaniesAndFundsHeldDirectlyManaged
-49124000 USD
CY2015Q1 pre Increase Decrease In Net Tax Assets And Liabilities
IncreaseDecreaseInNetTaxAssetsAndLiabilities
37445000 USD
CY2016Q1 pre Increase Decrease In Net Tax Assets And Liabilities
IncreaseDecreaseInNetTaxAssetsAndLiabilities
-4072000 USD
CY2015Q1 pre Increase Decrease In Reinsurance Balances Net
IncreaseDecreaseInReinsuranceBalancesNet
-572301000 USD
CY2016Q1 pre Increase Decrease In Reinsurance Balances Net
IncreaseDecreaseInReinsuranceBalancesNet
-480517000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1313468000 USD
CY2015Q1 pre Increase Decrease In Reinsurance Recoverable On Paid And Unpaid Losses Net Of Ceded Premiums Payable
IncreaseDecreaseInReinsuranceRecoverableOnPaidAndUnpaidLossesNetOfCededPremiumsPayable
45691000 USD
CY2016Q1 pre Increase Decrease In Reinsurance Recoverable On Paid And Unpaid Losses Net Of Ceded Premiums Payable
IncreaseDecreaseInReinsuranceRecoverableOnPaidAndUnpaidLossesNetOfCededPremiumsPayable
50856000 USD
CY2015Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
141672000 USD
CY2016Q1 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
134735000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-83283000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-63192000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3982147000 USD
CY2016Q1 pre Net Tax Assets
NetTaxAssets
82405000 USD
CY2015Q4 pre Net Tax Liabilities
NetTaxLiabilities
218652000 USD
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2537359000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36200000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
242760000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
235717000 USD
CY2015Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-2504000 USD
CY2016Q1 pre Net Tax Liabilities
NetTaxLiabilities
197973000 USD
CY2015Q4 pre Other Invested Assets Carried At Fair Value
OtherInvestedAssetsCarriedAtFairValue
190899000 USD
CY2016Q1 pre Other Invested Assets Carried At Fair Value
OtherInvestedAssetsCarriedAtFairValue
254924000 USD
CY2015Q1 pre Other Transaction Costs
OtherTransactionCosts
31000000 USD
CY2016Q1 pre Other Transaction Costs
OtherTransactionCosts
66000000 USD
CY2015Q4 pre Preference Shares Aggregate Liquidation Value
PreferenceSharesAggregateLiquidationValue
853750000 USD
CY2016Q1 pre Preference Shares Aggregate Liquidation Value
PreferenceSharesAggregateLiquidationValue
853750000 USD
CY2015Q1 pre Share Awards Outstanding Settled Upon Change In Control Value
ShareAwardsOutstandingSettledUponChangeInControlValue
0 USD
CY2016Q1 pre Share Awards Outstanding Settled Upon Change In Control Value
ShareAwardsOutstandingSettledUponChangeInControlValue
-75311000 USD
CY2016Q1 pre Special Dividend Amoun Paid
SpecialDividendAmounPaid
150000000 USD
CY2016Q1 pre Special Dividend Per Share Paid
SpecialDividendPerSharePaid
3.00
CY2015Q1 pre Underwriting Result
UnderwritingResult
117000000 USD
CY2016Q1 pre Underwriting Result
UnderwritingResult
-3000000 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
411539000 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
192994000 USD
CY2015Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-29911000 USD
CY2016Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-22522000 USD
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87237220 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
87237000 USD
CY2016Q1 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
33506000 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-30362000 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6293000 USD
CY2015Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2016Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2015Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2016Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2015Q1 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
2232000 USD
CY2016Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
21123000 USD
CY2016Q1 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
7892000 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
683000 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
9072000 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
304357000 USD
CY2015Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
275791000 USD
CY2016Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
282974000 USD
CY2015Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
629372000 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
74566000 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
46661000 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
32173000 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 USD
CY2016Q1 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
691117000 USD
CY2015Q4 us-gaap Deposit Contracts Assets
DepositContractsAssets
88152000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
250047000 USD
CY2015Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3838000 USD
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3467000 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 USD
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
769384000 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1027763000 USD
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
767255000 USD
CY2016Q1 us-gaap Deposit Contracts Assets
DepositContractsAssets
82018000 USD
CY2015Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
44420000 USD
CY2016Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
14184000 USD
CY2015Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
74328000 USD
CY2016Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
191609000 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
13147000 USD
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2074000 USD
CY2015Q4 us-gaap Funds Held Under Reinsurance Agreements Asset
FundsHeldUnderReinsuranceAgreementsAsset
657815000 USD
CY2016Q1 us-gaap Funds Held Under Reinsurance Agreements Asset
FundsHeldUnderReinsuranceAgreementsAsset
685564000 USD
CY2015Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
115645000 USD
CY2015Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
10222000 USD
CY2016Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
12335000 USD
CY2015Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
25904000 USD
CY2016Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
7076000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
33159000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
36747000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
33159000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
36747000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
21900000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
22007000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
47916000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
39808000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
47916000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
39808000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
20975000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
30327000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-14757000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-3061000 USD
CY2015Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2016Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2015Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
14184000 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
818720000 USD
CY2016Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
167193000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
456380000 USD
CY2016Q1 us-gaap Goodwill
Goodwill
456380000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
238000000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
145000000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
331602000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79665000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30954000 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
42257000 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
16019000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
76800000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
56386000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
34992000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6741000 USD
CY2015Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
418493000 USD
CY2016Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
359002000 USD
CY2015Q1 us-gaap Increase Decrease In Unearned Premiums Net
IncreaseDecreaseInUnearnedPremiumsNet
-418493000 USD
CY2016Q1 us-gaap Increase Decrease In Unearned Premiums Net
IncreaseDecreaseInUnearnedPremiumsNet
-359002000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
133011000 USD
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
126423000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
12245000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
12259000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q1 us-gaap Investment Income Net
InvestmentIncomeNet
104631000 USD
CY2016Q1 us-gaap Investment Income Net
InvestmentIncomeNet
102987000 USD
CY2015Q4 us-gaap Investments
Investments
14338015000 USD
CY2016Q1 us-gaap Investments
Investments
13836705000 USD
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14529609000 USD
CY2016Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14059457000 USD
CY2015Q4 us-gaap Junior Subordinated Notes
JuniorSubordinatedNotes
70989000 USD
CY2016Q1 us-gaap Junior Subordinated Notes
JuniorSubordinatedNotes
70989000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
14503092000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
15045278000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21406043000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21955463000 USD
CY2015Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
9064711000 USD
CY2016Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
9331087000 USD
CY2015Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
2051935000 USD
CY2016Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
2089055000 USD
CY2015Q4 us-gaap Minority Interest
MinorityInterest
2450000 USD
CY2016Q1 us-gaap Minority Interest
MinorityInterest
0 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-122829000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-262987000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
114775000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
337791000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
138747000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
91657000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
245917000 USD
CY2015Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
7391000 USD
CY2016Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
31425000 USD
CY2015Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
721281000 USD
CY2016Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
714268000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
34150000 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
34150000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
34150000 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
34150000 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
34150000 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
34150000 USD
CY2015Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
1234722000 USD
CY2016Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
1141716000 USD
CY2015Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
2428020000 USD
CY2016Q1 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
2964950000 USD
CY2015Q1 us-gaap Premiums Written Net
PremiumsWrittenNet
1653215000 USD
CY2016Q1 us-gaap Premiums Written Net
PremiumsWrittenNet
1500718000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
215626000 USD
CY2015Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2182000 USD
CY2016Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
231733000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
201442000 USD
CY2015Q4 us-gaap Other Assets
OtherAssets
31254000 USD
CY2016Q1 us-gaap Other Assets
OtherAssets
265013000 USD
CY2015Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-436000 USD
CY2016Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-829000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3157000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20091000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-217000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-203000 USD
CY2015Q1 us-gaap Other Expenses
OtherExpenses
124750000 USD
CY2016Q1 us-gaap Other Expenses
OtherExpenses
152674000 USD
CY2015Q1 us-gaap Other Income
OtherIncome
4292000 USD
CY2016Q1 us-gaap Other Income
OtherIncome
4840000 USD
CY2015Q4 us-gaap Other Investments
OtherInvestments
399204000 USD
CY2016Q1 us-gaap Other Investments
OtherInvestments
458709000 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
573000 USD
CY2016Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
49036000 USD
CY2015Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
71376000 USD
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2015Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
47369000 USD
CY2016Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
200614000 USD
CY2015Q1 us-gaap Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment
ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment
161229000 USD
CY2016Q1 us-gaap Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment
ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment
160065000 USD
CY2015Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
12692000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
44496000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
248099000 USD
CY2015Q4 us-gaap Trading Securities Short Term Investments Amortized Cost
TradingSecuritiesShortTermInvestmentsAmortizedCost
46689000 USD
CY2016Q1 us-gaap Trading Securities Short Term Investments Amortized Cost
TradingSecuritiesShortTermInvestmentsAmortizedCost
33536000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
39303068 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3266552000 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2015Q4 us-gaap Unearned Premiums
UnearnedPremiums
1644757000 USD
CY2016Q1 us-gaap Unearned Premiums
UnearnedPremiums
2086332000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
215626000 USD
CY2015Q4 us-gaap Reinsurance Payable
ReinsurancePayable
246089000 USD
CY2016Q1 us-gaap Reinsurance Payable
ReinsurancePayable
293342000 USD
CY2015Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
282916000 USD
CY2016Q1 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
300731000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6146802000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4401868000 USD
CY2015Q1 us-gaap Revenues
Revenues
1459290000 USD
CY2016Q1 us-gaap Revenues
Revenues
1416736000 USD
CY2015Q4 us-gaap Senior Notes
SeniorNotes
750000000 USD
CY2016Q1 us-gaap Senior Notes
SeniorNotes
750000000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
-251921 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
267918 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
46688000 USD
CY2016Q1 us-gaap Short Term Investments
ShortTermInvestments
33555000 USD
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15997 shares
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
7197145000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
6900501000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
6910185000 USD
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7254828000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6902951000 USD
CY2016Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6910185000 USD
CY2015Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
13448262000 USD
CY2016Q1 us-gaap Trading Securities Debt
TradingSecuritiesDebt
13020014000 USD
CY2015Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
13313819000 USD
CY2016Q1 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
12668635000 USD
CY2015Q4 us-gaap Trading Securities Equity
TradingSecuritiesEquity
443861000 USD
CY2016Q1 us-gaap Trading Securities Equity
TradingSecuritiesEquity
324427000 USD
CY2015Q4 us-gaap Trading Securities Equity Cost
TradingSecuritiesEquityCost
418428000 USD
CY2016Q1 us-gaap Trading Securities Equity Cost
TradingSecuritiesEquityCost
326909000 USD
CY2016Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany accounts and transactions have been eliminated.</font></div></div>
CY2016Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3. Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2015, the Financial Accounting Standards Board (FASB) issued updated guidance on the consolidation of voting interest entities and variable interest entities. The update required entities to reevaluate whether they should consolidate certain legal entities. This guidance is effective for interim and annual periods beginning after December 15, 2015, with early adoption permitted. The adoption of the guidance on January 1, 2016 did not have a significant impact on the Company&#8217;s Condensed Consolidated Financial Statements and disclosures.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In&#160;February 2016,&#160;the FASB&#160;issued updated guidance on the accounting for leases. This update requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous guidance and expands required disclosures. The guidance is effective for interim and annual periods beginning after December&#160;15, 2018, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this guidance on its Consolidated Financial Statements and disclosures.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In&#160;March 2016,&#160;the FASB&#160;issued updated guidance on the transition to the equity method of accounting. This update eliminates the requirement to retroactively adjust the carrying value of an investment when it qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence. The guidance is effective for interim and annual periods beginning after December&#160;15, 2016, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this guidance on its Consolidated Financial Statements.</font></div></div>
CY2016Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PartnerRe Ltd. (PartnerRe or the Company) predominantly provides reinsurance and certain specialty insurance lines on a worldwide basis through its principal wholly-owned subsidiaries, including Partner Reinsurance Company Ltd., Partner Reinsurance Europe SE, Partner Reinsurance Company of the U.S. and Partner Reinsurance Asia Pte. Ltd. Risks reinsured include, but are not limited to, property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, mortality, longevity, accident and health and alternative risk products. The Company&#8217;s alternative risk products include weather and credit protection to financial, industrial and service companies on a worldwide basis.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 2, 2015, the Company entered into an Agreement and Plan of Merger (the Merger Agreement) with Exor N.V., Pillar Ltd., a wholly owned subsidiary of Exor N.V., and solely with respect to certain specified sections thereof, EXOR S.p.A. (EXOR), a European investment company controlled by the Agnelli family, whereby Pillar Ltd. would be merged with and into the Company, with the Company continuing as the surviving company and a wholly owned subsidiary of Exor N.V. (the Merger).</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 19, 2015, the Merger was approved by the Company&#8217;s shareholders, pending certain regulatory approvals and other customary closing conditions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 18, 2016, the Company announced completion of the acquisition by EXOR following receipt of all regulatory approvals. Pursuant to the terms of the Merger Agreement, each PartnerRe common share issued and outstanding immediately prior to the effective time of the Merger was cancelled and converted into </font><font style="font-family:inherit;font-size:10pt;">$137.50</font><font style="font-family:inherit;font-size:10pt;"> in cash per share and entitled to receive a one-time special pre-closing cash dividend in the amount of </font><font style="font-family:inherit;font-size:10pt;">$3.00</font><font style="font-family:inherit;font-size:10pt;"> per common share (Special Dividend). </font><font style="font-family:inherit;font-size:10pt;">One</font><font style="font-family:inherit;font-size:10pt;"> common share at </font><font style="font-family:inherit;font-size:10pt;">$1.00</font><font style="font-family:inherit;font-size:10pt;"> par value was issued to Exor N.V., representing </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> common share ownership of the Company, and the Company paid the Special Dividend of approximately </font><font style="font-family:inherit;font-size:10pt;">$150 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, under the terms of the Merger Agreement, EXOR paid cash of approximately of </font><font style="font-family:inherit;font-size:10pt;">$42.7 million</font><font style="font-family:inherit;font-size:10pt;"> in aggregate to the holders of record of the Company&#8217;s preferred shares on March 18, 2016.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the terms of the Merger Agreement, PartnerRe common shares are no longer traded on the New York Stock Exchange (NYSE). The Company&#8217;s preferred shares continue to be traded on the NYSE following the closing of the transaction.</font></div></div>
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While Management believes that the amounts included in the Condensed Consolidated Financial Statements reflect its best estimates and assumptions, actual results could differ from those estimates. The Company&#8217;s principal estimates include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unpaid losses and loss expenses;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Policy benefits for life and annuity contracts;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross and net premiums written and net premiums earned;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recoverability of deferred acquisition costs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recoverability of deferred tax assets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation of goodwill and intangible assets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation of certain assets and derivative financial instruments that are measured using significant unobservable inputs.</font></div></td></tr></table></div>

Files In Submission

Name View Source Status
0000911421-16-000093-index-headers.html Edgar Link pending
0000911421-16-000093-index.html Edgar Link pending
0000911421-16-000093.txt Edgar Link pending
0000911421-16-000093-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pre-20160331.xml Edgar Link completed
pre-20160331.xsd Edgar Link pending
pre-20160331_cal.xml Edgar Link unprocessable
pre-20160331_def.xml Edgar Link unprocessable
pre-20160331_lab.xml Edgar Link unprocessable
pre-20160331_pre.xml Edgar Link unprocessable
q1201610-q.htm Edgar Link pending
q12016exhibit15.htm Edgar Link pending
q12016exhibit311.htm Edgar Link pending
q12016exhibit312.htm Edgar Link pending
q12016exhibit32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending